相似文献
1
Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.
Nat Chem Biol. 2014 Apr;10(4):248-50. doi: 10.1038/nchembio.1459. Epub 2014 Feb 23.
2
In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
Clin Appl Thromb Hemost. 2010 Aug;16(4):377-86. doi: 10.1177/1076029610366439. Epub 2010 May 11.
3
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.
Science. 2011 Oct 28;334(6055):498-501. doi: 10.1126/science.1207478.
4
Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Anal Bioanal Chem. 2011 Jan;399(2):763-71. doi: 10.1007/s00216-010-4220-8. Epub 2010 Oct 5.
5
The design and synthesis of new synthetic low-molecular-weight heparins.
J Thromb Haemost. 2016 Jun;14(6):1135-45. doi: 10.1111/jth.13312. Epub 2016 Apr 15.
6
Preparation and evaluation a new generation of low molecular weight heparin.
Biomed Pharmacother. 2016 Apr;79:194-200. doi: 10.1016/j.biopha.2016.02.021. Epub 2016 Mar 9.
7
Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Thromb Res. 2009 May;124(1):149-55. doi: 10.1016/j.thromres.2008.12.047. Epub 2009 Feb 4.
8
Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chloride.
Thromb Res. 1994 Jan 15;73(2):85-93. doi: 10.1016/0049-3848(94)90083-3.
9
Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.
Future Med Chem. 2012 Mar;4(3):289-96. doi: 10.4155/fmc.11.185.
10
Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats.
J Pharmacol Exp Ther. 2020 Apr;373(1):51-61. doi: 10.1124/jpet.119.262931. Epub 2020 Jan 14.
引用本文的文献
1
Characterization of Heparin Interactions With Recombinant Rodent Stabilin-2/Hyaluronic Acid Receptor for Endocytosis (HARE).
Proteoglycan Res. 2025 Apr;3(2). doi: 10.1002/pgr2.70027. Epub 2025 Apr 7.
2
Efficient Small-Molecule Reversal Agents for Anticoagulant Fondaparinux.
ACS Pharmacol Transl Sci. 2025 Apr 29;8(5):1333-1346. doi: 10.1021/acsptsci.4c00747. eCollection 2025 May 9.
3
The effect of ultrasonic-assisted enzymes extraction on antioxidant polysaccharide activity in dandelion.
Ultrason Sonochem. 2025 May;116:107329. doi: 10.1016/j.ultsonch.2025.107329. Epub 2025 Mar 28.
4
Editor's Choice Development of a method to measure the activity of heparan sulfate 6-endosulfatase for biological research.
Glycobiology. 2025 Feb 28;35(4). doi: 10.1093/glycob/cwaf012.
5
Structural and Functional Analysis of Heparosan Synthase 2 from (PmHS2) to Improve the Synthesis of Heparin.
ACS Catal. 2024 May 3;14(9):6577-6588. doi: 10.1021/acscatal.4c00677. Epub 2024 Apr 15.
6
Bioengineered production of glycosaminoglycans and their analogues.
Syst Microbiol Biomanuf. 2021 Apr;1(2):123-130. doi: 10.1007/s43393-020-00011-x. Epub 2020 Aug 17.
7
Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation.
Nat Commun. 2023 Sep 18;14(1):5777. doi: 10.1038/s41467-023-41453-w.
8
Control of tissue homeostasis by the extracellular matrix: Synthetic heparan sulfate as a promising therapeutic for periodontal health and bone regeneration.
Periodontol 2000. 2024 Feb;94(1):510-531. doi: 10.1111/prd.12515. Epub 2023 Aug 24.
9
Increased 3--sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene .
Sci Adv. 2023 May 26;9(21):eadf6232. doi: 10.1126/sciadv.adf6232.
10
A 6-O-endosulfatase activity assay based on synthetic heparan sulfate oligomers.
Glycobiology. 2023 Jun 3;33(5):384-395. doi: 10.1093/glycob/cwad026.
本文引用的文献
1
Scientific considerations in the review and approval of generic enoxaparin in the United States.
Nat Biotechnol. 2013 Mar;31(3):220-6. doi: 10.1038/nbt.2528.
2
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.
Nat Med. 2013 Apr;19(4):446-51. doi: 10.1038/nm.3102. Epub 2013 Mar 3.
3
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.
Anal Chem. 2012 Oct 16;84(20):8822-9. doi: 10.1021/ac302232c. Epub 2012 Sep 26.
4
Probing structural selectivity of synthetic heparin binding to Stabilin protein receptors.
J Biol Chem. 2012 Jun 15;287(25):20774-83. doi: 10.1074/jbc.M111.320069. Epub 2012 Apr 30.
5
Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis.
J Biol Chem. 2012 Jun 15;287(25):20996-1002. doi: 10.1074/jbc.M112.359885. Epub 2012 Apr 23.
6
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin.
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5265-70. doi: 10.1073/pnas.1117923109. Epub 2012 Mar 19.
7
Synthetic heparin.
Curr Opin Pharmacol. 2012 Apr;12(2):217-9. doi: 10.1016/j.coph.2011.12.002. Epub 2012 Feb 8.
8
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e195S-e226S. doi: 10.1378/chest.11-2296.
9
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.
Science. 2011 Oct 28;334(6055):498-501. doi: 10.1126/science.1207478.
10
Chemistry. Getting the farm out of pharma for heparin production.
Science. 2011 Oct 28;334(6055):462-3. doi: 10.1126/science.1211605.
Zotero 插件